1st Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

High Throughput Technology for Hit Generation

 Virtual Event    June 2-3

Keynote Speaker

Targeting RNA With Small Molecules Using Affinity-Selection Mass Spectrometry

Dr Elliot B. NICKBARG
Dr Elliot B. NICKBARG
MERCK & CO., INC, Boston, United States
Read more

Speakers

More Than My Title: The Power of AS-MS in Drug Discovery

Dr Eric X. SHI
Dr Eric X. SHI
GLAXOSMITHKLINE LLC, Cambridge, United States
Read more

Adapting ASMS Technology to GPCR Ligand Discovery

Prof. Wenqing SHUI
Prof. Wenqing SHUI
SHANGHAITECH UNIVERSITY, Shanghai, China
Read more

MALDI-TOF AS-MS – a Viable Alternative for LC-MS-based Workflows?

Dr Roman SIMON
Dr Roman SIMON
BOEHRINGER INGELHEIM, Ulm, Baden-Württemberg, Germany
Read more

Lessons Learned from Pfizer’s Experience in utilizing Affinity Selection by Mass Spectrometry for Hit Identification

Dr Matthew D. TROUTMAN
Dr Matthew D. TROUTMAN
PFIZER, INC., Groton, United States
Read more

Title to be announced

Prof. Richard  VAN BREEMEN
Prof. Richard VAN BREEMEN
OREGON STATE UNIVERSITY, Corvallis, United States